Cite
COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation
MLA
Shi, Wenjie, et al. COL11A1 as an Novel Biomarker for Breast Cancer with Machine Learning and Immunohistochemistry Validation. Jan. 2022. EBSCOhost, https://doi.org/10.17169/refubium-36396.
APA
Shi, W., Chen, Z., Liu, H., Miao, C., Feng, R., Wang, G., Chen, G., Chen, Z., Fan, P., Pang, W., & Li, C. (2022). COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation. https://doi.org/10.17169/refubium-36396
Chicago
Shi, Wenjie, Zhilin Chen, Hui Liu, Chen Miao, Ruifa Feng, Guilin Wang, Guoping Chen, et al. 2022. “COL11A1 as an Novel Biomarker for Breast Cancer with Machine Learning and Immunohistochemistry Validation,” January. doi:10.17169/refubium-36396.